The Diagnostic Value of the Systemic Immune-Inflammation Index for Venous Thromboembolism in Lung Cancer Patients: A Retrospective Study

Table 4

Comparison of clinical data between VTE groups and non-VTE groups.

Variate	Univariate		Multivariate
	OR (95% CI)	-value	OR (95% CI)	-value
Female	1.372 (0.844-2.231)	0.203
Age>65	2.378 (1.446-3.940)	0.001	2.403 (1.321-4.370)	0.004
BMI>28	1.349 (0.536-3.393)	0.525
Smoking	0.893 (0.547-1.458)	0.650
Vessel disease	1.098 (0.113-10.694)	0.936
Pathological type		0.040
Adenocarcinoma	2.325 (1.166-4.635)	0.017
SCC	1.531 (0.703-3.335)	0.283
Metastasis	3.002 (1.822-4.944)	<0.001	2.380 (1.329-4.261)	0.004
Mutation	2.314 (1.349-3.972)	0.002
Antitumor therapy	2.040 (1.122-3.710)	0.019	2.414 (1.175-4.956)	0.016
WBC>11 × 10^9/L	5.920 (2.464-14.225)	<0.001
HB<100(g/L)	3.422 (1.541-7.600)	0.003	3.844 (1.420-10.409)	0.008
PLT>350 × 10^9/L	2.732 (1.409-5.297)	0.003
CRP>7.29 mg/L	2.078 (1.274-3.387)	0.003
Hypoproteinemia	2.326 (1.337-4.045)	0.003
D-dimer>2 folds	5.856 (3.454-9.928)	<0.001	4.083(2.238-7.447)	<0.001
NLR>3.99	5.634 (3.293-9.639)	<0.001
PLR>198.86	4.896 (2.898-8.272)	<0.001
LMR>2.20	3.946 (2.159-7.215)	<0.001
SII>851.51 × 10^9/L	6.407 (3.798-10.808)	<0.001	3.355 (1.849-6.088)	<0.001

Notes: OR: the odds ratio.